Qilian International Holding Group Limited (QLI)

NASDAQ: QLI · IEX Real-Time Price · USD
1.19
+0.03 (2.59%)
At close: Sep 29, 2022 4:00 PM
1.22
+0.03 (2.52%)
After-hours: Sep 29, 2022 4:00 PM EDT
2.59%
Market Cap 42.54M
Revenue (ttm) 57.10M
Net Income (ttm) 3.15M
Shares Out 35.75M
EPS (ttm) 0.09
PE Ratio 13.22
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,370
Open 1.20
Previous Close 1.16
Day's Range 1.19 - 1.22
52-Week Range 1.01 - 4.04
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About QLI

Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce co... [Read more...]

Industry Drug Manufacturers-Specialty & Generic
IPO Date Jan 12, 2021
Employees 283
Stock Exchange NASDAQ
Ticker Symbol QLI
Full Company Profile

Financial Performance

In 2021, QLI's revenue was $57.10 million, an increase of 14.12% compared to the previous year's $50.03 million. Earnings were $3.15 million, a decrease of -37.74%.

Financial Statements

News

Qilian International Holding Group Limited Reports Fiscal Year 2021 Financial Results

JIUQUAN, China, Feb. 11, 2022 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company", "Qilian International", "we", "our" or "us"), a China-based pharmaceutical and chem...

7 months ago - PRNewsWire

Qilian International Holding Group Limited Receives Approval for the Sale of its Newly Developed Nitrofurantoin Enter...

JIUQUAN, China, Jan. 19, 2022 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company", "Qilian International", "we", "our" or "us"), a China-based pharmaceutical and chem...

8 months ago - PRNewsWire

Qilian International Holding Group Limited Releases 2022 Chairman Letter

JIUQUAN, China, Jan. 11, 2022 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company", "Qilian International", "we", "our" or "us"), a China-based pharmaceutical and chem...

8 months ago - PRNewsWire

Qilian International Holding Group Limited Announces Inclusion of Gan Di Xin® and Qilian Shan® Oxytetracycline into L...

JIUQUAN, China, Nov. 23, 2021 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and chemical products manufacturer, today announced t...

10 months ago - PRNewsWire

Qilian International Holding Group Limited Announces Initiation of Development of New Drug for Gastric Cancer Prevention

JIUQUAN, China, Nov. 15, 2021 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and chemical products manufacturer, announced that th...

10 months ago - PRNewsWire

Qilian International Holding Group Limited Donates Pharmaceutical Products Gan Di Xin® Worth RMB500,000 and Other Mat...

JIUQUAN, China, Nov. 1, 2021 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and chemical products manufacturer, announced that rec...

11 months ago - PRNewsWire

Qilian International Holding Group Limited Completes Phase One of Its Expansion of New Organic Fertilizer Production ...

JIUQUAN, China, Oct. 26, 2021 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and chemical products manufacturer, today announced t...

11 months ago - PRNewsWire

Qilian International Holding Group Limited Received Approval for Oxytetracycline API Export to Egypt

JIUQUAN, China, Oct. 13, 2021 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and chemical products manufacturer, announced that on...

11 months ago - PRNewsWire

Qilian International Holding Group Limited Reports Financial Results for the First Six Months of Fiscal Year 2021

Jiuquan, China, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announ...

1 year ago - GlobeNewsWire

Qilian International Holding Group Limited Signs Agreement with District Government, Settling the Project in Local Hi...

Jiuquan, China, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announc...

1 year ago - GlobeNewsWire

Qilian International Holding Group Limited Enters into Investment Agreement for Pig By-product Processing Project in ...

Jiuquan, China, July 09, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announc...

1 year ago - GlobeNewsWire

Qilian International Holding Group Limited Announces Inclusion of 16 Products into China's National Reimbursement Dru...

Jiuquan, China, April 13, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announ...

1 year ago - GlobeNewsWire

Qilian International Holding Group Limited Reports Fiscal Year 2020 Financial Results

Jiuquan, China, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announc...

1 year ago - GlobeNewsWire

Qilian International Holding Group Limited to Triple Organic Fertilizer Production Capacity by March 2021

Jiuquan, China, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announc...

1 year ago - GlobeNewsWire

Univest Securities, LLC. Announces Closing of IPO for its Client Qilian International Holding Group Limited (Nasdaq: ...

New York, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, is a full-service investment bank and securities broker-dealer firm based in New York, today ...

1 year ago - GlobeNewsWire

Qilian International Holding Group Limited Announces Closing of Initial Public Offering

Jiuquan, China, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (the “Company”) (Nasdaq: QLI), a China-based pharmaceutical and chemical products manufacturer, today announc...

1 year ago - GlobeNewsWire

Qilian IPO: 10 Things for Potential QLI Stock Investors to Know About the Chinese Pharma

Qilian (QLI) is catching the eyes of investors on Tuesday as shares of its stock started trading today via the company's IPO. The post Qilian IPO: 10 Things for Potential QLI Stock Investors to Know Abo...

1 year ago - InvestorPlace

Qilian International Holding Group Limited Announces Pricing of Initial Public Offering

Jiuquan, China, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announced the pricing...

1 year ago - GlobeNewsWire